Yumiko Yamamoto

Dr. Yumiko Yamamoto

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1996 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
KOKaori Okakura‐Mochizuki
Kaori Okakura‐Mochizuki
TMTakatoshi Mochizuki
Takatoshi Mochizuki
YYYumiko Yamamoto
Yumiko Yamamoto
AHArata Horii
Arata Horii
AYAtsushi Yamatodani
Atsushi Yamatodani

1 August 2020
Verified
Journal Article
Closed access
YYYumiko Yamamoto
Yumiko Yamamoto
YHYoshihiro Hayashi
Yoshihiro Hayashi
IMIchiro Murakami
Ichiro Murakami

8 August 2021 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
YYYumiko Yamamoto
Yumiko Yamamoto
YHYoshihiro Hayashi
Yoshihiro Hayashi
HSHideyuki Sakaki
Hideyuki Sakaki
IMIchiro Murakami
Ichiro Murakami
Fascin‑1, an actin‑bundling protein, is associated with poor prognosis in patients with various types of human carcinoma. However, research is limited on the role of fascin‑1 in sarcoma. Solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are rare sarcomas derived from the mesenchyme. Although the prognosis of SFT/HPC is generally favorable, fatalities are possible with repeated recurrence and distant metastasis. The current study included a total of 20 Japanese patients, who were diagnosed with SFT/HPC and underwent surgery at Kochi University Hospital from January 2000 to December 2019. The statistical relationship between recurrence and the following variables were examined: Sex, age of onset, tumor origin, tumor size, necrosis, mitosis ≥1/10 high power field (HPF; magnification, x400), Ki‑67 >5% and Fascin‑1. A significant association was determined between recurrence and necrosis, mitosis ≥1/10 HPF (magnification, x400), Ki‑67 >5%, and Fascin‑1 ≥‘strongly positive’ (P<0.05). The results demonstrated that Fascin‑1 immunostaining may be a highly effective and useful evaluation factor for predicting poor prognosis in patients with SFT/HPC, a fatal sarcoma of humans.

17 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
YYYumiko Yamamoto
Yumiko Yamamoto
YHYoshihiro Hayashi
Yoshihiro Hayashi
HSHideyuki Sakaki
Hideyuki Sakaki
IMIchiro Murakami
Ichiro Murakami
For melanoma treatment, an early diagnosis and a complete resection of the primary tumor is essential. In addition, detection of factors that may be related to metastasis is indispensable. A total of 30 Japanese patients with Stage I or II melanoma, diagnosed according to the classification of the American Joint Committee on Cancer, are included in this study. Clinical background (sex, onset age, primary tumor area, existence of remaining cancer cells at the resected tissue margin, and treatment after the primary surgery) and immunohistochemical staining (Nestin and Fascin) on the resected tissue were examined to detect factors statistically related to metastasis. The analysis result has shown that older onset age and positive immunohistochemical expressions of Nestin and Fascin are statistically related to metastasis. To facilitate meticulous observation of Nestin and Fascin expression at different timing (e.g., onset and metastasis), double immunofluorescence staining was performed. Nestin is a class VI intermediate filament protein, initially detected in neural stem cells. Fascin is an actin-bundling protein which regulates cell adhesion, migration and invasion. Nestin and Fascin are suggested to relate to melanoma metastasis, however, the potential role of Fascin is controversial. Analysis of variations in Fascin expression detected in this study may contribute to further investigations concerning potential roles of Fascin for progression of melanoma. This is the first study to report double immunofluorescent staining of Nestin and Fascin in melanoma. Nestin and Fascin double-positive melanoma cells were detected.

1 August 2023 in Medical Molecular Morphology
Verified
Journal Article
Closed access
PDF file
YHYoshihiro Hayashi
Yoshihiro Hayashi
YYYumiko Yamamoto
Yumiko Yamamoto
IMIchiro Murakami
Ichiro Murakami

20 January 2022 in Medical Molecular Morphology
Verified
Journal Article
Closed access
PDF file
YHYoshihiro Hayashi
Yoshihiro Hayashi
YYYumiko Yamamoto
Yumiko Yamamoto
IMIchiro Murakami
Ichiro Murakami